The dispute centres on Novo Nordisk's Indian patents for semaglutide, which it markets globally as Ozempic and Wegovy for ...

This comes just under a month after Pfizer finalised a deal to acquire Metsera following a bidding war with Novo Nordisk.

TALLAHASSEE, Fla. — From fentanyl testing for suspected overdose patients and regulations for surrendered infants, to diabetes management in schools and liability for property damage in a hit-and-run, ...

Obesity is the excessive or abnormal accumulation of fat or adipose tissue in the body that impairs health via its ...

Aleniglipron showed a tolerability profile that is consistent with the GLP-1 receptor agonist class.

Australia's TGA has added mental health warnings to Ozempic and other GLP-1 drugs after reports of depression and suicidal ...

The WHO has officially recommended GLP-1 drugs, such as semaglutide, for treating obesity in adults at high risk of weight-related complications. Citing strong evidence for significant weight loss and ...

Going into next year, 42% of employers cited health care cost control for both the organization and its employees as their No ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related ...

The market for GLP-1 drugs is projected to reach $180 billion in 2034, according to Morningstar Equity Research. Current ...

Recent estimates suggest that about 60% of the nation’s cats and dogs have obesity; hundreds of thousands of cats and dogs ...

From a seismic election in the nation's biggest city to a trendy pair of flip-flops, 2025 had some tricky words for some ...